Open Beta
TREN
MetriLume
TREN

US marketsSBFMW

SEC-sourced researchBeta

SBFMW

Sunshine Biopharma Inc.

Company comparison ↗

Data passport

CIK
0001402328
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 34,874,283.0000 USD; December 2025: 36,305,891.0000 USD36.3M USD0 USD0December 2024December 2025
SBFMW · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202434,874,283.0000Apr 3, 2026
December 202536,305,891.0000Apr 3, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202536,305,891.0000-5,975,352.0000-5,331,073.000030,079,167.00007,040,707.0000Apr 3, 2026
December 202434,874,283.0000-5,134,116.0000-12,524,779.000030,560,392.00007,059,638.0000Apr 3, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$36.31MDecember 2025Apr 3, 202610-K
Previous period revenueRevenues$34.87MDecember 2024Apr 3, 202610-K
Net incomeNetIncomeLoss-$5.98MDecember 2025Apr 3, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.33MDecember 2025Apr 3, 202610-K
Total assetsAssets$30.08MDecember 2025Apr 3, 202610-K
Total liabilitiesLiabilities$7.04MDecember 2025Apr 3, 202610-K

New filings

Explore methodology ↗